Clinically Proven with Funding from the National Institutes of Health, SAM® Offers Significant, Effective Soft Tissue Injury Healing and Pain Relief That Most Alternatives Do Not

TRUMBULL, Conn., Aug. 26, 2020 /PRNewswire/ — Sustained Acoustic Medicine (SAM®) from ZetrOZ Systems offers significant, effective healing and pain relief for soft tissue injuries that the majority of alternatives simply do not. The life-changing benefits of sam® include the following:

  • Reduction in the cause of pain
  • Acceleration of the healing process
  • Delivery of mechanical compression and deep heat
  • Increase of deep circulation
  • Enhancement of oxygen and nutrient delivery
  • Application of multiple hours per day of therapy on a daily basis

A side-by-side review of alternatives to sam® reveals that these treatments fall short when compared to the miniaturized wearable ultrasound device.

  • Joint injection biologics and hyaluronic acid injections lack:
  • Delivery of mechanical compression and deep heat
  • Increase of deep circulation
  • Enhancement of oxygen and nutrient delivery
  • A device that is wearable and portable

Bracing solutions lack:

  • Reduction in the cause of pain
  • Acceleration of the healing process
  • Delivery of mechanical compression and deep heat
  • Enhancement of oxygen and nutrient delivery
  • Increase of deep circulation
  • Application of multiple hours of therapy per day on a daily basis

Electrical and magnetic stimulation lack:

  • Reduction in the cause of pain
  • Acceleration of the healing process
  • Delivery of mechanical compression and deep heat
  • Enhancement of oxygen and nutrient delivery

Cold compression lacks:

  • Reduction in the cause of pain
  • Acceleration of the healing process
  • Delivery of deep heat
  • Enhancement of oxygen and nutrient delivery
  • Increase of deep circulation

Taking a long-duration, low-intensity approach, SAM® utilizes ultrasonic waves over a period of four hours to increase circulation, modulate cellular activity and minimize pain. This process gives the wearable device the ability to inhibit inflammatory pathways and stimulate soft tissue repair at injury sites and in common chronic pain conditions.

SAM® is a viable option for avoiding narcotic medication and postponing surgery. If surgery becomes necessary, the treatment improves postoperative healing and surgical outcomes. SAM® is especially beneficial for patients whose healing capability is diminished. The device also administers effective relief from pain that can result from conditions such as arthritis, back spasms, disk herniation and tendonitis. Multiple clinical trials by investigators at the University of Miami, Brigham Young University, Albert Einstein College of Medicine, and other clinical centers of excellence demonstrate the effectiveness of SAM® in the peer-reviewed medical literature.

“In developing SAM® and collaborating with top-tier American healthcare institutions, we took into account the shortcomings of other treatments and made it a point to solve those issues. Patients who wear the user-friendly device for just four hours per day experience compelling benefits they will not find elsewhere. There simply is no truly comparable alternative,” said Dr. George Lewis, chief executive officer of ZetrOZ Systems.

About ZetrOZ Systems

ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.com and samrecover.com.

Related Images

sam-is-a-breakthrough-medical.jpg
sam® is a breakthrough medical innovation to accelerate the remodeling of tissue and collagen matrix rebuilding. Manufactured in the USA.

View original content to download multimedia:http://www.prnewswire.com/news-releases/clinically-proven-with-funding-from-the-national-institutes-of-health-sam-offers-significant-effective-soft-tissue-injury-healing-and-pain-relief-that-most-alternatives-do-not-301119003.html

SOURCE ZetrOZ Systems

Staff

Recent Posts

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

40 minutes ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

40 minutes ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

40 minutes ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

40 minutes ago

HCAP Partners Announces Investment in Puzzle Healthcare

Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions…

40 minutes ago

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation…

40 minutes ago